TY  - GEN
AU  - Melaiu,Ombretta
AU  - Mina,Marco
AU  - Chierici,Marco
AU  - Boldrini,Renata
AU  - Jurman,Giuseppe
AU  - Romania,Paolo
AU  - D'Alicandro,Valerio
AU  - Benedetti,Maria C
AU  - Castellano,Aurora
AU  - Liu,Tao
AU  - Furlanello,Cesare
AU  - Locatelli,Franco
AU  - Fruci,Doriana
TI  - PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
SN  - 1557-3265
PY  - 2018///0619
KW  - Adolescent
KW  - Adult
KW  - Antigens, CD
KW  - genetics
KW  - Azepines
KW  - administration & dosage
KW  - B7-H1 Antigen
KW  - Biomarkers, Tumor
KW  - Cell Line, Tumor
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Genes, MHC Class I
KW  - Humans
KW  - Infant
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - N-Myc Proto-Oncogene Protein
KW  - Neuroblastoma
KW  - drug therapy
KW  - Prognosis
KW  - Programmed Cell Death 1 Receptor
KW  - Proto-Oncogene Proteins c-myc
KW  - Triazoles
KW  - Lymphocyte Activation Gene 3 Protein
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-16-2601
ER  -